MDMA-Assisted Therapy for PTSD: A Conversation With Amy Emerson, CEO of Lykos Therapeutics
CLINICAL CONVERSATIONS The US Food and Drug Administration (FDA) Advisory Committee Meeting will meet on June 4, 2024, to review investigational MDMA-assisted therapy for posttraumatic stress disorder (PTSD). In advance of this meeting, we asked Amy …